All News

Top news of the day from across the health care landscape.

Dogs were previously the leading cause of rabies deaths in the United States, but now bats are considered the major threat.

Study findings suggest that triple-negative breast cancer incidence among black women is not generalizable to all women of African descent.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

Officials with the FDA approved Amgen’s trastuzumab-anns, also known as ABP 980 (Kanjinti), the fifth FDA-approved biosimilar referencing trastuzumab (Herceptin).

The approval of Amgen’s trastuzumab-anns, the fifth biosimilar to Herceptin, marks the twentieth biosimilar approved by the FDA.

Investigators aim to develop cellular models to mimic the biological processes responsible for the onset of multiple sclerosis.

Slow walking speed associated with higher risk of poor outcomes for older patients with blood cancers.

A new study finds duel benefit of the varicella vaccine

Genentech is seeking approval for rituximab (Rituxan) with glucocorticoids for pediatric patients with granulomatosis with polyangiitis and microscopic polyangiitis.

Patients with hemophilia A across all age groups reported stabilization or improvement of quality of life and high treatment satisfaction.

The trial analyzed the impact of vitamin K intake on patients who were taking warfarin to decrease the risk of blood clots.

Top news of the day from across the health care landscape.